Transitional cell carcinoma
Active Research Protocols
- 09-C-0214 – A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine (FdCyd + THU)
- 11-C-0227 – Multi-Center Phase 1B/II Trial of Gemcitabine, Cisplatin, Plus Lenalidomide as First Line Therapy for Patients with Metastatic Urothelial Carcinoma
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014